ABC Arbitrage SA Sells 11,970 Shares of Amedisys, Inc. (NASDAQ:AMED)

Key Points

• ABC Arbitrage SA reduced its holdings in Amedisys, Inc. by 43.1% in the first quarter, owning 15,812 shares valued at $1,465,000 after selling 11,970 shares.
• Amedisys reported an earnings per share (EPS) of $1.54 for the last quarter, surpassing the consensus estimate of $1.39, with revenues of $621.86 million.
• Analysts recently adjusted Amedisys' ratings, with Wall Street Zen downgrading it from "strong-buy" to "buy", while the Royal Bank of Canada maintains an "outperform" rating with a target price of $100.

ABC Arbitrage SA lowered its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 43.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,812 shares of the health services provider's stock after selling 11,970 shares during the quarter. ABC Arbitrage SA's holdings in Amedisys were worth $1,465,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Amedisys by 56.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after buying an additional 120 shares in the last quarter. Fifth Third Bancorp increased its position in shares of Amedisys by 68.1% in the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after buying an additional 141 shares in the last quarter. Gamco Investors INC. ET AL increased its position in shares of Amedisys by 0.5% in the 4th quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock valued at $2,754,000 after buying an additional 159 shares in the last quarter. Hexagon Capital Partners LLC increased its position in shares of Amedisys by 108.1% in the 1st quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock valued at $29,000 after buying an additional 161 shares in the last quarter. Finally, UMB Bank n.a. increased its position in shares of Amedisys by 100.0% in the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock valued at $36,000 after buying an additional 193 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th. Royal Bank Of Canada reiterated an "outperform" rating and set a $100.00 target price on shares of Amedisys in a report on Wednesday, April 16th.

Amedisys Stock Up 0.1%

AMED stock traded up $0.06 during trading hours on Friday, reaching $100.94. 684,123 shares of the stock were exchanged, compared to its average volume of 637,016. The firm's 50-day moving average is $97.35 and its 200-day moving average is $94.43. The company has a market cap of $3.32 billion, a price-to-earnings ratio of 39.28, a PEG ratio of 1.35 and a beta of 0.89. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.36 and a quick ratio of 1.36. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $100.99.

Amedisys (NASDAQ:AMED - Get Free Report) last released its earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.15. The firm had revenue of $621.86 million during the quarter, compared to analysts' expectations of $614.61 million. Amedisys had a return on equity of 12.91% and a net margin of 3.56%. The company's revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 EPS. On average, equities research analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.